Jefferies Raises Price Target on EnerSys (ENS) to $39
Get Alerts ENS Hot Sheet
Price: $183.86 --0%
Rating Summary:
11 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 30
Rating Summary:
11 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 30
Join SI Premium – FREE
Jefferies boosted estimates and its price target on EnerSys (NYSE: ENS) from $29 to $39 on "flawless" executive and solid fundamentals. The firm reiterated their Buy rating.
The firm comments, "ENS is benefiting from a very resilient replacement business in the Reserve segment and strong truck orders in Motive; we see these trends sustaining at least through the end of FY12. Continued acquisitions and buildouts in developing markets will drive growth in FY13 and beyond; management has consistently executed on this strategy. We increase our estimates and raise our PT to $39; we remain conservative in our baseline assumptions."
The firm boosted Q4 EPS from $0.68 to $0.88, FY12 from $2.62 to $2.92 and FY13 from $2.99 to $3.23.
For an analyst ratings summary and ratings history on EnerSys click here. For more ratings news on EnerSys click here.
Shares of EnerSys closed at $33.24 yesterday.
The firm comments, "ENS is benefiting from a very resilient replacement business in the Reserve segment and strong truck orders in Motive; we see these trends sustaining at least through the end of FY12. Continued acquisitions and buildouts in developing markets will drive growth in FY13 and beyond; management has consistently executed on this strategy. We increase our estimates and raise our PT to $39; we remain conservative in our baseline assumptions."
The firm boosted Q4 EPS from $0.68 to $0.88, FY12 from $2.62 to $2.92 and FY13 from $2.99 to $3.23.
For an analyst ratings summary and ratings history on EnerSys click here. For more ratings news on EnerSys click here.
Shares of EnerSys closed at $33.24 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
- Jefferies Reiterates Buy Rating on Five Below (FIVE)
- Jefferies Reiterates Hold Rating on Lululemon (LULU)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share